Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumors

NCT04871282 is registered in ClinicalTrials.gov with Immunome, Inc. as lead sponsor.

NCT NCT04871282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04871282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumors
Lead sponsor
Immunome, Inc.
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
September 1, 2021
Completion date
December 31, 2026
Enrollment
198 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

desmoid, desmoid tumor